4/A//SEC Filing
RUDELL ROBERT A 4/A
Accession 0001140361-10-051194
CIK 0000739944other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 2:49 PM ET
Size
5.8 KB
Accession
0001140361-10-051194
Insider Transaction Report
Form 4/AAmended
RUDELL ROBERT A
Director
Transactions
- Award
Common Stock
2010-12-21$12.09/sh+1,339$16,189→ 54,783 total
Footnotes (3)
- [F1]Shares are attributable to a deferral of one-half of directors annual fees and are subject to vesting and a substantial risk of forfeiture. Shares have been acquired either in a private transaction or in the open market and are exempt under Rule 16b-3.
- [F2]This Form 4/A is being filed solely for the purpose of correcting clerical data entry errors to reflect that 1,339 shares were acquired not 1,266 as originally reported.
- [F3]This Form 4/A is being filed solely for the purpose of correcting clerical data entry errors to reflect that the number of beneficially-owned shares held directly by the reporting person is 54,783, not 60,379 as originally reported.
Documents
Issuer
MEDTOX SCIENTIFIC INC
CIK 0000739944
Entity typeother
Related Parties
1- filerCIK 0001184610
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 2:49 PM ET
- Size
- 5.8 KB